Lv1
14 积分 2023-07-09 加入
Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy
4个月前
已完结
The Lasting Impact of IL-2: Approaching 50 Years of Advancing Immune Tolerance, Cancer Immunotherapies, and Autoimmune Diseases
4个月前
已完结
Revisiting IL-2: Biology and therapeutic prospects
4个月前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
8个月前
已完结
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
10个月前
已完结
Differentiating IL-23 Inhibitors in Crohn’s Disease
10个月前
已完结
Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease
10个月前
已完结
Protease-resistant single-domain antibodies inhibit Campylobacter jejuni motility
10个月前
已关闭
An oral interleukin-23- receptor antagonist peptide for plaque psoriasis
10个月前
已完结
An ingestible self-orienting system for oral delivery of macromolecules
10个月前
已完结
皖公网安备34019202002308
